In the article by Juan Tamargo entitled Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments (European Cardiology Review 2019;14(1):23–32. https://doi.org/10.15420/ecr.2018.34.2), the following correction should be made:
Figure 1 should indicate an increase (↑) in haemoglobin and haematocrit, not a decrease (↓). The corrected figure appears below.
The author apologises for this error.